Залізодефіцит та залізодефіцитна анемія: як впоратися з цією проблемою

Iron deficiency (ID) is the most common micronutrient deficiency, affecting almost a third of the population, and is the leading cause of iron deficiency anemia (IDA) worldwide. IDA is a global health problem as it contributes to the global burden of disease.Anemia during pregnancy, most often caused by iron or folic acid deficiency, is associated with increased risk of maternal mortality and other adverse outcomes, including premature labor, placental abruption, preeclampsia, eclampsia, cesarean section, postpartum hemorrhage, postpartum infection, birth of a newborn not corresponding to gestational age, as well as increased perinatal and neonatal mortality rates. In addition, being born to a mother with anemia increases the risk of cognitive development disorders in early childhood and neurological disorders, such as autism spectrum disorders and attention deficit disorder. Among women of reproductive age, the most common causes of ID and IDA are abnormal uterine bleeding (AUB) and uncorrected iron loss from previous pregnancies. Based on health care system data, AUB occurs much more frequently than usually assumed. Given the prevalence of 20–30% among women of reproductive age, it can negatively impact quality of life and is associated with financial losses, reduced productivity, poor health, and greater use of medical services.Given the global nature of the problem of iron deficiency, the World Health Organization called for community efforts to reduce the incidence of anemia in women of reproductive age. Exogenous iron and folic acid supplementation is a proven effective strategy in reducing the incidence of ID and IDA. The priority of this area justifies the urgent need of society for new highly effective molecules with a broad safety profile for both the prevention and treatment of ID and IDA. A significant achievement of modern pharmacology was the creation of the dietary supplement, which includes iron bisglycinate chelate. Adding IV generation folate to the dietary supplement improves iron deficiency recovery results.

Publication Details

Journal
Scientific periodicals of Ukraine
Published
2025-06-30
Primary Topic
Iron Metabolism and Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Залізодефіцит та залізодефіцитна анемія: як впоратися з цією проблемою

Scientific periodicals of Ukraine
Iron Metabolism and Disorders
article

Залізодефіцит та залізодефіцитна анемія: як впоратися з цією проблемою

article en

Abstract

Iron deficiency (ID) is the most common micronutrient deficiency, affecting almost a third of the population, and is the leading cause of iron deficiency anemia (IDA) worldwide. IDA is a global health problem as it contributes to the global burden of disease.Anemia during pregnancy, most often caused by iron or folic acid deficiency, is associated with increased risk of maternal mortality and other adverse outcomes, including premature labor, placental abruption, preeclampsia, eclampsia, cesarean section, postpartum hemorrhage, postpartum infection, birth of a newborn not corresponding to gestational age, as well as increased perinatal and neonatal mortality rates. In addition, being born to a mother with anemia increases the risk of cognitive development disorders in early childhood and neurological disorders, such as autism spectrum disorders and attention deficit disorder. Among women of reproductive age, the most common causes of ID and IDA are abnormal uterine bleeding (AUB) and uncorrected iron loss from previous pregnancies. Based on health care system data, AUB occurs much more frequently than usually assumed. Given the prevalence of 20–30% among women of reproductive age, it can negatively impact quality of life and is associated with financial losses, reduced productivity, poor health, and greater use of medical services.Given the global nature of the problem of iron deficiency, the World Health Organization called for community efforts to reduce the incidence of anemia in women of reproductive age. Exogenous iron and folic acid supplementation is a proven effective strategy in reducing the incidence of ID and IDA. The priority of this area justifies the urgent need of society for new highly effective molecules with a broad safety profile for both the prevention and treatment of ID and IDA. A significant achievement of modern pharmacology was the creation of the dietary supplement, which includes iron bisglycinate chelate. Adding IV generation folate to the dietary supplement improves iron deficiency recovery results.

Scientific periodicals of Ukraine
No poverty
Openalex Percentile: Top 33%
Iron Metabolism and Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.